Patents by Inventor Hansjorg Adam

Hansjorg Adam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
    Publication number: 20090041775
    Abstract: Use of a CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence, the hypervariable regions CDR1, CDR2 and CDR3; said CDR1 having the amino acid sequence Arg-Tyr-Trp-Met-His, said CDR2 having the amino acid sequence Ala-Ile-Tyr-Pro-Gly-Asn-Ser-Asp-Thr-Ser-Tyr-Asn-Gln-Lys-Phe-Glu-Gly, and said CDR3 having the amino acid sequence Asp-Tyr-Gly-Tyr-Tyr-Phe-Asp-Phe, in the treatment of inflammatory disease of the gastro-intestinal tract.
    Type: Application
    Filed: February 29, 2008
    Publication date: February 12, 2009
    Inventors: Hansjorg Adam, Lothar Farber
  • Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract
    Publication number: 20050226872
    Abstract: Use of a CD25 binding molecule which comprises at least one antigen binding site comprising at least one domain which comprises in sequence, the hypervariable regions CDR1, CDR2 and CDR3; said CDR1 having the amino acid sequence Arg-Tyr-Trp-Met-His (SEQ ID NO:1), said CDR2 having the amino acid sequence Ala-Ile-Tyr-Pro-Gly-Asn-Ser-Asp-Thr-Ser-Tyr-Asn-Gln-Lys-Phe-Glu-Gly (SEQ ID NO:2), and said CDR3 having the amino acid sequence Asp-Tyr-Gly-Tyr-Tyr-Phe-Asp-Phe (SEQ ID NO:3), in the treatment of inflammatory disease of the gastro-intestinal tract.
    Type: Application
    Filed: March 28, 2001
    Publication date: October 13, 2005
    Inventors: Hansjorg Adam, Lothar Farber